Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
- Published in:
- Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0204-6
- By:
- Publication type:
- Article
Works matching DE "NARCOTIC agonists"
Results: 14
1
2
Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.
- Published in:
- Journal of Cheminformatics, 2016, v. 8, p. 1, doi. 10.1186/s13321-016-0154-2
- By:
- Publication type:
- Article
3
History of Methadone and Buprenorphine Opioid Agonist Therapy Among People Who Died of an Accidental Opioid-Involved Overdose: Rhode Island, January 1, 2018–June 30, 2020.
- Published in:
- American Journal of Public Health, 2021, v. 111, n. 9, p. 1600, doi. 10.2105/ajph.2021.306395
- By:
- Publication type:
- Article
4
Low‐ and very low‐dose buprenorphine induction: new(ish) uses for an old(ish) medication?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
5
Opioid overdose deaths and the expansion of opioid agonist treatment: a population‐based prospective cohort study.
- Published in:
- Addiction, 2022, v. 117, n. 5, p. 1363, doi. 10.1111/add.15739
- By:
- Publication type:
- Article
6
Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada.
- Published in:
- Addiction, 2022, v. 117, n. 5, p. 1353, doi. 10.1111/add.15737
- By:
- Publication type:
- Article
7
Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia.
- Published in:
- Addiction, 2022, v. 117, n. 5, p. 1338, doi. 10.1111/add.15736
- By:
- Publication type:
- Article
8
Commentary on Jin et al. (2020): Expanding the impact of opioid agonist therapy for opioid use disorder—are there lessons from the HIV/AIDS response?
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
9
Global opioid agonist treatment: a review of clinical practices by country.
- Published in:
- Addiction, 2020, v. 115, n. 12, p. 2243, doi. 10.1111/add.15087
- By:
- Publication type:
- Article
10
Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.
- Published in:
- Addiction, 2016, v. 111, n. 2, p. 298, doi. 10.1111/add.13193
- By:
- Publication type:
- Article
11
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 3, p. 254, doi. 10.1177/0269881114565142
- By:
- Publication type:
- Article
12
Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
13
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.
- Published in:
- 2019
- By:
- Publication type:
- journal article
14
Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
- Published in:
- Clinical Toxicology (15563650), 2017, v. 55, n. 5, p. 338, doi. 10.1080/15563650.2017.1287373
- By:
- Publication type:
- Article